African Vaccine Regulatory Forum (AVAREF)
The ninth annual meeting of the African Vaccine Regulatory Forum (AVAREF) will take place in Pretoria, South Africa from 3 to 7 November 2014. The first two days of the meeting will be devoted to Ebola Virus Disease (EVD) emergency and will address topics such as pipeline of potential therapeutics (vaccines, drugs and blood products), GSK ChAd3 and Newlink/NIH VSV candidate Ebola vaccines, clinical trial designs for vaccines and the ways of their expedited approval, regulatory pathways for approval of vaccines and the use of blood therapies. The meeting will bring together public health officials, regulatory and industrial experts in an attempt to facilitate and expedite the development, regulatory review and use of new vaccines and other therapies against EVD.
The expected outcomes of the meeting include mechanisms and clear pathways for expedited regulatory review of clinical trials and approval of products that are being developed to address EVD emergency, agreement on timelines and joint review by regulators and ethics committees of clinical trial applications by AVAREF countries, WHO assistance to facilitate these processes, and endorsement of a panel of safety experts to review safety data of new products and relevant communication with National Regulatory Authorities.
For any further questions please send an email to:
Dr Dicky Akanmori (email@example.com)
Dr Ahmed Bellah (firstname.lastname@example.org)